Evidence map›Paper›PMID 24722012›Full record

ArticleScientific reports2014

Upstream Transcription Factor 1 (USF1) allelic variants regulate lipoprotein metabolism in women and USF1 expression in atherosclerotic plaque.

Yue-Mei Fan, Jussi Hernesniemi, Niku Oksala, Mari Levula, Emma Raitoharju, Auni Collings, Nina Hutri-Kähönen, Markus Juonala, Jukka Marniemi, Leo-Pekka Lyytikäinen and 15 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Heliyon · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 11 institutions in 3 countries.

Yue-Mei FanDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere University Hospital and School of Medicine at the University of Tampere, Tampere.
Jussi HernesniemiDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere University Hospital and School of Medicine at the University of Tampere, Tampere.
Niku Oksala1] Department of Clinical Chemistry, Fimlab Laboratories, Tampere University Hospital and School of Medicine at the University of Tampere, Tampere [2] Divison of Vascular Surgery, Department of Surgery, Tampere University Hospital and University of Tampere, Finland.
Mari LevulaDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere University Hospital and School of Medicine at the University of Tampere, Tampere.
Emma RaitoharjuDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere University Hospital and School of Medicine at the University of Tampere, Tampere.
Auni CollingsDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere University Hospital and School of Medicine at the University of Tampere, Tampere.
Nina Hutri-KähönenDepartment of Pediatrics, University of Tampere and Tampere University Hospital, Tampere.
Markus JuonalaResearch Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku.
Jukka MarniemiDepartment of Health and Functional Capacity, Population Research Laboratory, National Public Health Institute.
Leo-Pekka LyytikäinenDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere University Hospital and School of Medicine at the University of Tampere, Tampere.
Ilkka SeppäläDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere University Hospital and School of Medicine at the University of Tampere, Tampere.
Ari MennanderHeart Center, Department of Cardiac Surgery, Tampere University Hospital, Finland.
Matti TarkkaHeart Center, Department of Cardiac Surgery, Tampere University Hospital, Finland.
Antti J Kangas1] Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland [2] NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Pasi Soininen1] Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland [2] NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Juha Pekka SaleniusDivison of Vascular Surgery, Department of Surgery, Tampere University Hospital and University of Tampere, Finland.
Norman KloppInstitute of Epidemiology, Helmholtz Center Munich, Munich, 85764, Germany.
Thomas IlligInstitute of Epidemiology, Helmholtz Center Munich, Munich, 85764, Germany.
Tomi LaitinenDepartment of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland, Finland.
Mika Ala-Korpela1] Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland [2] NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland [3] Oulu University Hospital, Oulu, Finland [4] Computational Medicine, School of Social and Community Medicine & Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
Reijo LaaksonenDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere University Hospital and School of Medicine at the University of Tampere, Tampere.
Jorma ViikariDepartment of Medicine, University of Turku and Division of Medicine, Turku University Hospital, Turku, Finland.
Mika KähönenDepartment of Clinical Physiology, University of Tampere and Tampere University Hospital, Tampere.
Olli T RaitakariResearch Centre of Applied and Preventive Cardiovascular Medicine, University of Turku and Department of Clinical Physiology, University of Turku and Turku University Hospital, Turku, Finland.
Terho LehtimäkiDepartment of Clinical Chemistry, Fimlab Laboratories, Tampere University Hospital and School of Medicine at the University of Tampere, Tampere.
Fimlab (Finland) · FITampere University · FITampere University · FITampere University Hospital · FIHelmholtz Zentrum München · DEUniversity of Oulu · FIUniversity of Turku · FIKuopio University Hospital · FIPublic Health Institute · USTurku University Hospital · FIUniversity of Eastern Finland · FI

Funding

Medical Research Council MC_UU_12013/1
6 · The paper itself

Abstract

Upstream transcription factor 1 (USF1) allelic variants significantly influence future risk of cardiovascular disease and overall mortality in females. We investigated sex-specific effects of USF1 gene allelic variants on serum indices of lipoprotein metabolism, early markers of asymptomatic atherosclerosis and their changes during six years of follow-up. In addition, we investigated the cis-regulatory role of these USF1 variants in artery wall tissues in Caucasians. In the Cardiovascular Risk in Young Finns Study, 1,608 participants (56% women, aged 31.9 ± 4.9) with lipids and cIMT data were included. For functional study, whole genome mRNA expression profiling was performed in 91 histologically classified atherosclerotic samples. In females, serum total, LDL cholesterol and apoB levels increased gradually according to USF1 rs2516839 genotypes TT < CT < CC and rs1556259 AA < AG < GG as well as according to USF1 H3 (GCCCGG) copy number 0 < 1 < 2. Furthermore, the carriers of minor alleles of rs2516839 (C) and rs1556259 (G) of USF1 gene had decreased USF1 expression in atherosclerotic plaques (P = 0.028 and 0.08, respectively) as compared to non-carriers. The genetic variation in USF1 influence USF1 transcript expression in advanced atherosclerosis and regulates levels and metabolism of circulating apoB and apoB-containing lipoprotein particles in sex-dependent manner, but is not a major determinant of early markers of atherosclerosis.

Indexed as

AdultAllelesApolipoproteins BAtherosclerosisCholesterol, LDLFemaleGenotypeHaplotypesHumansLipid MetabolismMalePlaque, AtheroscleroticPolymorphism, Single NucleotideProspective StudiesRisk FactorsSex FactorsApolipoproteins BCholesterol, LDLUpstream Stimulatory FactorsUSF1 protein, human

Identifiers

PMID24722012
PMCPMC3983598
OpenAlexW2163941104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.